Burjeel Cancer Institute Forges Global Collaborations to Enhance Cancer Care in the Region
In a major step toward expanding access to world-class oncology services, Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has announced strategic collaborations with three globally renowned institutions — the European Institute of Oncology (IEO), the Children's Hospital of Philadelphia (CHOP), and SJD Barcelona Children's Hospital — during Abu Dhabi Global Healthcare Week. These partnerships aim to redefine oncology care in the region by advancing clinical services, research, education, and personalized oncology.
BCI caters to over 5,000 patients each year and provides 360-degree tailored care, from diagnosis to survivorship programs. Its network is spread across the entire UAE, including key locations in Abu Dhabi, Al Ain, Dubai, Sharjah, and Al Dhafra, ensuring access to comprehensive and compassionate cancer care across all ages.
These new collaborations will leverage teleconsultation and remote patient monitoring technologies, facilitate second opinions from international experts, and establish visiting programs to enable deeper knowledge exchange and enhance local capabilities.
Enhancing Pediatric Cancer Care
The Children's Hospital of Philadelphia (CHOP) collaboration will enhance pediatric cancer care and strengthen capabilities in advanced diagnostics, remote consultations, and multidisciplinary second opinions. Visiting programs from CHOP will support knowledge exchange in subspecialized pediatric oncology.
Mrs. Madeline Bell – President & Chief Executive Officer (CEO) for Children's Hospital of Philadelphia (CHOP), said 'We are excited to collaborate with BCI in advancing pediatric cancer care through shared expertise, remote care innovations, and training opportunities. Together, we will empower healthcare teams and support families facing childhood cancer.'
The partnership with SJD Barcelona Children's Hospital is set to further augment BCI's capabilities in comprehensive childhood cancer care. The collaboration will offer continuous remote support and medical guidance, particularly for rare and complex pediatric cases.
Dr. Manel del Castillo Rey – Chief Executive Officer (CEO) SJD Barcelona Children's Hospital, commented, 'Our collaboration with BCI provides a framework for sharing specialized knowledge and co-managing complex pediatric oncology cases. By bridging geographies, we can provide more children with access to expert care.'
Integrating Global Expertise
In partnership with the European Institute of Oncology (IEO), BCI will focus on strengthening cancer care in the UAE through clinical and scientific research development, training and education programs for healthcare professionals, and high-level clinical services. The collaboration will also support the creation of a distinguished network of visiting professors, capacity-building initiatives for nurses and pharmacists, and the establishment of a strategic advisory board for BCI.
Ing. Mauro Melis – Chief Executive Officer IEO & Centro Cardiologico Monzino, said, 'Our partnership with Burjeel Cancer Institute reflects a shared commitment to elevating standards in cancer care. Through collaborative research, clinical exchanges, and capacity-building, we aim to jointly accelerate innovation and improve outcomes for patients in the country and across the region.'
Advancing Diagnostic Testing for Cancer
In addition to these collaborations, Burjeel Cancer Institute also joined hands with AbbVie Biopharmaceuticals to advance a personalized medicine approach in cancer care. The collaboration aims to support the adoption and access to the latest testing techniques to enhance the diagnosis and treatment of patients with various types of cancer, including ovarian, lung, and colorectal malignancies. As part of this initiative, the anatomical pathology laboratory lead by Dr. Rawia Mubarak will introduce a test for the first time in the region for platinum-resistant ovarian cancer, which will help identify patients who may benefit from emerging targeted therapies—offering a more personalized path forward and renewed hope for better outcomes. Mr. Mohammad Aboubakr Abdulgawad Mohammad – General Manager for AbbVie Pharmaceuticals, said,'Through our collaboration with Burjeel Cancer Institute, we are proud to introduce this advanced test in the UAE, a critical step toward identifying individuals who may benefit from emerging targeted therapies. By adopting this innovation, physicians can offer a more personalized and effective approach to care.'
Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute, remarked, 'These global partnerships are a pivotal step in our mission to bring world-class cancer care to the region. By aligning with some of the most prestigious institutions worldwide, we are building a future-ready oncology ecosystem that prioritizes quality, access, and innovation for every patient we serve.'
These partnerships underscore BCI's strategic vision to not only expand its clinical capabilities but also serve as a regional hub for knowledge, innovation, and excellence in oncology.
Follow Emirates 24|7 on Google News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
12-05-2025
- Web Release
Aster Al Raffah Walk Again Launch Advanced Robotic Rehabilitation Centre in Oman
Aster Al Raffah Hospitals & Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre. Located in Al Ghubra, Muscat, this first-of-its-kind facility in the Sultanate marks a significant milestone in healthcare innovation, poised to transform neuro-rehabilitation across the region. The facility was inaugurated by His Excellency Dr. Ahmed bin Salim Al-Mandhari, Undersecretary for Planning and Health Regulation, Ministry of Health, Sultanate of Oman, alongside; Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics – UAE, Oman, Bahrain; Mr. Shailesh Guntu, Deputy CEO of Aster Hospitals, UAE & Oman; Mr. Rahul Kadavakolu, Group Chief Marketing Officer, Aster DM Healthcare; Dr. Sachin Kandhari, CEO of Walk Again India, and other distinguished guests. Aster Al Raffah Walk Again is Oman's one of the first private hospital to introduce a specialized robotic rehabilitation facility. It offers a multidisciplinary approach to recovery, utilizing advanced robotic technologies to support patients with neurological, spinal, stroke-related, and sports injuries. Spanning three floors, the centre provides specialized rehabilitation for a wide range of conditions, including stroke, spinal cord injury (SCI), traumatic brain injury (TBI), cerebral palsy, multiple sclerosis, and motor neuron diseases, among others. The facility serves both pediatric and adult patients, with provisions for international care. The centre is designed as a multidisciplinary facility of excellence, specializing in Neurology, Spine, and Sports Medicine, ensuring holistic care for patients recovering from complex injuries and neurological disorders. A key highlight of the centre is the Cyberdyne HAL, a robotic exoskeleton that assists patients with mobility impairments, enabling walking and limb movement by interpreting bioelectric signals from muscles. Other cutting-edge technologies include the Recoverix Pro system, which uses Brain-Computer Interface (BCI) for stroke and multiple sclerosis rehabilitation, and Vibramoov, a vibration therapy system that enhances gait and mobility. Additional innovations such as Luna EMG, a neurorehabilitation system, and Meissa OT, a robotic upper limb rehabilitation device, ensure comprehensive recovery for patients with varied needs. The centre also offers advanced neuromodulation treatments, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for treatment-resistant epilepsy. These technologies, along with Functional Electrical Stimulation, enhance muscle strength and coordination, supporting patients in regaining independence. The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre is supported by a team of nationally and internationally recognized specialists in Neurosciences, Orthopedics, Spine, and Rheumatology. Leading the clinical team is Dr. Ali Al Balushi, Consultant – Vascular Neurologist & Neurointerventionalist at Aster Al Raffah Hospitals & Clinics, along with other esteemed doctors who bring extensive expertise in managing complex neurological and musculoskeletal conditions. By focusing on neuroplasticity, the process through which the brain reorganizes itself after injury, the Aster Al Raffah Walk Again Hospital facilitates recovery through a range of therapies tailored to individual needs. Utilizing US FDA-approved technologies, the centre aims to harness the brain's ability to form new neural connections, a critical element of rehabilitation following neurological conditions. His Excellency Dr. Ahmed Bin Salim Al Mandhari – Undersecretary for Planning & Health Regulation, Ministry of Health ,Sultanate of Oman, speaking about the launch, remarked, 'We are proud to inaugurate this world-class facility in Oman, which will help bring advanced rehabilitation care closer to home for our people. The launch of the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation hospital reflects our vision of building Oman as a leading hub for innovative healthcare. The Government of Oman and the Ministry of Health will continue to partner closely with the private health sector to ensure their success and to bring the best medical technologies to our country for the welfare of our people. This state-of-the-art rehabilitation solution will not only benefit citizens across Oman but will also attract patients from outside Oman, strengthening Oman's position as a destination for world-class treatment.' Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, commenting on the significance of the initiative, added, 'The Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital is a monumental step forward in providing accessible, world-class rehabilitation care to patients in Oman and the region. This facility is part of Aster's commitment to offering innovative healthcare solutions, and it will undoubtedly transform the lives of patients by offering hope and enabling recovery that was once thought impossible. Through our 'Treat in Oman' initiative, we aim to eliminate the need for residents to travel abroad for advanced care, making Oman a global leader in healthcare excellence.' Ms. Alisha Moopen, Managing Director & Group CEO of Aster DM Healthcare, commented, 'The launch of the Advanced Robotic Rehabilitation Hospital in Oman marks a defining moment in our mission to make cutting-edge, patient-centric care accessible to all. At Aster, we believe in transforming lives through innovation and compassion. This facility embodies that vision, providing hope and advanced recovery solutions to patients with neurological and musculoskeletal conditions. As we expand our footprint in Oman, we remain committed to raising the bar for specialized care and making the country a leading destination for healthcare excellence in the region.' Dr. Sachin Kandhari, CEO of Walk Again India, reflecting on the collaboration, said, 'As a leading provider of neuro-rehabilitation, Walk Again is excited to partner with Aster in bringing advanced robotic rehabilitation to Oman. Our mission is to help patients recover from spinal cord injuries, stroke, and other neurological disorders. Through this Hospital, we are committed to leveraging state-of-the-art technology and global expertise to provide the highest standards of care.' Walk Again brings a legacy of clinical excellence in neuro-rehabilitation, with a strong track record of integrating robotics with personalized treatment protocols. Through the technologies and expertise introduced at the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Hospital, patients in Oman now have access to globally benchmarked rehabilitation solutions without the need to travel abroad. In addition to clinical services, the centre is committed to advancing medical education and clinical research. It will actively engage in national and international conferences, further establishing its role as a leader in neuro-rehabilitation and innovation. This initiative significantly enhances Oman's healthcare sector and contributes to the Sultanate's broader vision of providing high-quality medical technologies and specialized services closer to home. As a regional centre of excellence, the facility is also expected to attract patients from across the GCC and African nations seeking advanced robotic rehabilitation. Through robotic rehabilitation, the centre aims to empower patients, helping them regain independence and improve their quality of life.
Gulf Today
22-04-2025
- Gulf Today
Burjeel Cancer Institute unveils new Breast Centre
Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has officially launched Burjeel Breast Centre, a first-of-its-kind facility offering comprehensive, multidisciplinary care for women with both malignant and benign breast conditions. The Centre was launched at a ceremony held in BMC in the presence of Dr. Rashed Obaid AlSuwaidi, Director General Abu Dhabi Public Health Center, Dr. Fayeza Saif Alyafei, Executive Director of the Healthcare Quality Sector, Department of Health - Abu Dhabi, and Muhammed Shihabuddin, Group Chief Financial Officer, Burjeel Holdings. Located within Burjeel Medical City, the centre is designed as a one-stop destination for breast health, integrating advanced diagnostics, personalised treatment, and dedicated support services under one roof. The facility has been designed to offer a seamless breast cancer screening experience — from initial screening to diagnosis and treatment — while reducing anxiety and streamlining the journey to recovery. According to experts, with early diagnosis, breast cancer recovery rates can exceed 95%, making timely intervention critical. The centre emphasises a patient-centred approach, where same-day appointments are offered, ensuring a diagnosis is provided during the patient's consultation. At the heart of the centre is a women-led medical team, composed of internationally recognised experts in breast health, including Dr. Nehad Abdul Razzaq Kazim Albastaki, Consultant Breast Imaging & Interventional Radiologist, an expert Emirati female doctor specialising in radiology and mammography. This all-female team ensures the highest levels of privacy, comfort, and individualised care for patients. Additionally, the AI-driven breast radiology system assists radiologists in interpreting mammograms, ultrasounds, and MRIs, ensuring accuracy and reducing the chances of false diagnoses. Burjeel Breast Center is launching the first-of-its-kind initiative, the 'Survivorship Lounge,' which is dedicated to empowering breast cancer survivors by providing a safe, supportive, and informative space focused on life after treatment. This lounge will offer personalised survivorship care plans, wellness resources, psychological support, lifestyle guidance, and education on long-term health. Enhancing its holistic approach, Burjeel Cancer Institute (BCI) is also launching Burjeel Cancer Institute Pharmacy. Burjeel Cancer Institute Pharmacy proudly holds the distinction of being the first dedicated cancer pharmacy in the UAE. 'The launch of Burjeel Breast Center reflects our commitment to raising the standard of women's healthcare in the region. By integrating diagnostics, expert consultation, and treatment into one cohesive space, we are delivering a seamless and supportive experience for patients,' said John Sunil, Group CEO of Burjeel Holdings.
Web Release
22-04-2025
- Web Release
Burjeel Cancer Institute Unveils New Breast Center to Elevate Women's Cancer Care
Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has officially launched Burjeel Breast Center, a first-of-its-kind facility offering comprehensive, multidisciplinary care for women with both malignant and benign breast conditions. The Center was launched at a ceremony held in BMC in the presence of Dr. Rashed Obaid AlSuwaidi, Director General Abu Dhabi Public Health Center, H.E. Dr. Fayeza Saif Alyafei, Executive Director of the Healthcare Quality Sector, Department of Health – Abu Dhabi, and Mr. Muhammed Shihabuddin, Group Chief Financial Officer, Burjeel Holdings. Located within Burjeel Medical City, the center is designed as a one-stop destination for breast health, integrating advanced diagnostics, personalized treatment, and dedicated support services under one roof. The facility has been designed to offer a seamless breast cancer screening experience—from initial screening to diagnosis and treatment—while reducing anxiety and streamlining the journey to recovery. According to experts, with early diagnosis, breast cancer recovery rates can exceed 95%, making timely intervention critical. The center emphasizes a patient-centered approach, where same-day appointments are offered, ensuring a diagnosis is provided during the patient's consultation. At the heart of the center is a women-led medical team, composed of internationally recognized experts in breast health, including Dr. Nehad Abdul Razzaq Kazim Albastaki Consultant Breast Imaging & Interventional Radiologist, an expert Emirati female doctor specializing in radiology and mammography. This all-female team ensures the highest levels of privacy, comfort, and individualized care for patients. Additionally, a special team specializing in breast reconstruction is available for cases requiring surgery and resection, further enhancing the care provided. At the center, samples are processed and delivered on the same day, ensuring a swift and accurate diagnosis. Equipped with cutting-edge technology, including HOLOGIC's 3Dimensions™ Mammography System, the center offers enhanced imaging for early and accurate detection of breast abnormalities. Additionally, the AI-driven breast radiology system assists radiologists in interpreting mammograms, ultrasounds, and MRIs, ensuring accuracy and reducing the chances of false diagnoses. As part of its comprehensive approach, the center also offers a survivorship program, empowering cancer survivors with the tools, support, and care they need to thrive post-treatment. Burjeel Breast Center is launching the first-of-its-kind initiative, the 'Survivorship Lounge,' which is dedicated to empowering breast cancer survivors by providing a safe, supportive, and informative space focused on life after treatment. This lounge will offer personalized survivorship care plans, wellness resources, psychological support, lifestyle guidance, and education on long-term health—ensuring that every survivor feels seen, supported, and strengthened throughout their post-treatment journey with dedicated team from physicians, psychologists & breastfeeding cancer survivors volunteers. 'Burjeel Breast Center reimagines the breast care journey by offering an empathetic, data-driven, and efficient clinical environment. By removing barriers to early detection—such as long wait times and the need for prior appointments—we are empowering women to take charge of their health. Early intervention is key, and our walk-in model ensures no time is lost. To enhance patient experience, we have integrated artificial intelligence into our workflow. The AI system can analyze patients' genetic and hereditary data, helping determine the most effective treatments based on each patient's unique characteristics,' said Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute. Burjeel Cancer Institute Pharmacy Launched Enhancing its holistic approach, Burjeel Cancer Institute (BCI) is also launching Burjeel Cancer Institute Pharmacy. Burjeel Cancer Institute Pharmacy proudly holds the distinction of being the first dedicated cancer pharmacy in the UAE. This specialized pharmacy is designed to cater exclusively to the needs of oncology patients, ensuring they have access to a comprehensive range of medications tailored to enhance their quality of life. By focusing specifically on cancer care, the pharmacy aims to provide personalized services, expert advice, and support for patients undergoing treatment. This initiative reflects Burjeel Cancer Institute's commitment to improving the overall patient journey by ensuring access to essential medicines and resources that can aid in their treatment and recovery. 'The launch of Burjeel Breast Center reflects our commitment to raising the standard of women's healthcare in the region. By integrating diagnostics, expert consultation, and treatment into one cohesive space, we are delivering a seamless and supportive experience for patients,' said John Sunil, Group CEO of Burjeel Holdings. The establishment of Burjeel Breast Center reinforces BCI's mission to lead in complex cancer care, setting new benchmarks in clinical excellence and innovation across the UAE and the region.
